Loading...
BVMFBALM4
Market cap19mUSD
Dec 23, Last price  
10.62BRL
1D
-8.45%
Name

Baumer SA

Chart & Performance

D1W1MN
BVMF:BALM4 chart
P/E
13.47
P/S
0.71
EPS
0.79
Div Yield, %
0.00%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
7.24%
Revenues
170m
-48.36%
45,654,00053,936,00065,106,00065,303,00074,055,00085,202,00094,812,00093,512,00099,746,000108,697,000116,297,000112,044,000113,105,000109,754,000119,803,000149,310,000325,946,000267,640,000329,088,000169,950,000
Net income
9m
+56.59%
1,273,0003,382,0005,421,0001,833,0004,215,0001,980,0003,717,0006,933,0008,458,00013,128,00011,497,00014,352,0003,016,000675,0002,753,0004,194,00016,431,00010,132,0005,709,0008,940,000
CFO
26m
+716.88%
578,0003,240,000201,0007,075,0001,503,0008,867,0005,034,0004,694,000766,0005,534,000-2,870,00014,527,00026,325,00017,635,0003,133,00025,593,000
Dividend
Dec 06, 20230.77647 BRL/sh

Profile

Baumer S.A. develops solutions in hospitals, odontology, and health industry equipment in Brazil, Europe, Asia, and the United States. It offers sterilization and infection control solutions, such as steam sterilizers, formoldehyde and hydrogen peroxide steam sterilizers, solid waste treatment systems, ethylene oxide sterilizers, thermal washer disinfectors, drying cabinets, ultrasonic reprocessors, preparation and storage systems, loading and water treatment systems, test and control, and steam generators. The company also provides surgical center solutions, including anesthesia systems, lighting products, and surgical tables; and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as pedicle fixation system, occipitocervial fixation systems, cervical cage angled, and posterior lumbar cages. Further, the company offers dental solutions, including implants and biomaterials. It serves hospitals, clinics, hemocenters, universities, public health service, and carrier health markets; and pharmaceutical, food, and cosmetics industries, as well as research institutes and laboratories. The company was founded in 1952 and is based in Pacaembu, Brazil.
URL
https://www.baumer.com.br/
IPO date
Jun 06, 1995
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
169,950
-48.36%
329,088
22.96%
267,640
-17.89%
Cost of revenue
146,650
141,728
120,806
Unusual Expense (Income)
NOPBT
23,300
187,360
146,834
NOPBT Margin
13.71%
56.93%
54.86%
Operating Taxes
5,673
3,968
3,297
Tax Rate
24.35%
2.12%
2.25%
NOPAT
17,627
183,392
143,537
Net income
8,940
56.59%
5,709
-43.65%
10,132
-38.34%
Dividends
(4,796)
(4,846)
Dividend yield
4.90%
3.82%
Proceeds from repurchase of equity
26
(4,058)
831
BB yield
-0.02%
4.15%
-0.65%
Debt
Debt current
3,791
6,673
6,199
Long-term debt
16,340
18,983
15,525
Deferred revenue
Other long-term liabilities
23,477
841
1,023
Net debt
(73,374)
13,365
5,306
Cash flow
Cash from operating activities
25,593
3,133
17,635
CAPEX
(5,423)
(6,078)
(4,810)
Cash from investing activities
(5,298)
(3,316)
(4,172)
Cash from financing activities
(4,154)
(489)
(1,102)
FCF
27,182
173,781
124,704
Balance
Cash
59,462
43,320
43,992
Long term investments
34,043
(31,029)
(27,574)
Excess cash
85,008
3,036
Stockholders' equity
145,599
134,590
131,723
Invested Capital
104,370
159,081
149,485
ROIC
13.38%
118.87%
101.58%
ROCE
12.18%
102.22%
84.68%
EV
Common stock shares outstanding
9,785
9,785
9,785
Price
11.52
15.20%
10.00
-22.96%
12.98
-17.32%
Market cap
112,718
15.20%
97,845
-22.96%
127,003
-17.33%
EV
40,703
112,262
133,810
EBITDA
28,168
191,466
151,442
EV/EBITDA
1.44
0.59
0.88
Interest
9,564
1,453
1,636
Interest/NOPBT
41.05%
0.78%
1.11%